+91-22-489139092019 ஆம் ஆண்டிற்கான சிறந்த 10 செயல்திறன் துறை நிதி
துறைபரஸ்பர நிதி ஒரு குறிப்பிட்ட துறைக்குச் சொந்தமான நிறுவனங்களின் பங்கு பங்குகளில் தங்கள் நிதிப் பணத்தின் பெரும்பகுதியை முதலீடு செய்யும் திட்டத்தைப் பார்க்கவும். இந்த திட்டங்கள் தேடும் நபர்களால் தேடப்படுகின்றனஉயர் வருமானம் அவர்களின் முதலீட்டில் ஒருஅதிக ஆபத்து பசியின்மை. மியூச்சுவல் ஃபண்டுகள் பொதுவாக தங்கள் திட்டங்களை வழங்கும் சில துறைகளில் உள்கட்டமைப்பு, மருந்து, வங்கி மற்றும் நிதி சேவைகள் மற்றும் இயற்கை வளங்கள் மற்றும் புதிய ஆற்றல் ஆகியவை அடங்கும். 2019 ஆம் ஆண்டிற்கான துறை நிதிகளின் செயல்திறன் கணிசமாக சிறப்பாக உள்ளது. பொருளாதாரத்தின் வளர்ச்சியுடன், பல துறை நிதிகள் தங்கள் முதலீடுகளுக்கு சாதகமான வருமானத்தை ஈட்டியுள்ளன. எனவே, 2019 ஆம் ஆண்டிற்கான சிறந்த மற்றும் சிறந்த 10 செயல்திறன் துறை மியூச்சுவல் ஃபண்டுகளில் சிலவற்றை அவற்றின் செயல்திறன் (வருமானம்) அடிப்படையில் பார்ப்போம்.
Talk to our investment specialist
செயல்திறனை அடிப்படையாகக் கொண்டு 2019 ஆம் ஆண்டிற்கான சிறந்த 10 செயல்திறன் துறை பரஸ்பர நிதிகள்
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) LIC MF Infrastructure Fund Growth ₹50.3335
↓ -0.10 ₹995 47.8 44.4 7.9 46.6 -0.1 UTI Healthcare Fund Growth ₹294.065
↓ -1.05 ₹1,119 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹434.72
↓ -3.67 ₹3,963 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹30.8535
↓ -0.14 ₹1,309 40.4 36.6 -8 19.1 64.4 Bandhan Infrastructure Fund Growth ₹50.322
↓ -0.27 ₹1,613 39.3 50.3 1.7 64.8 6.3 Franklin India Opportunities Fund Growth ₹260.986
↓ -1.38 ₹7,509 37.3 53.6 -1.9 29.7 27.3 Canara Robeco Infrastructure Growth ₹163.69
↑ 0.01 ₹889 35.3 41.2 9 56.1 9 Nippon India Pharma Fund Growth ₹515.509
↓ -2.04 ₹8,357 34 39.2 -9.9 23.9 66.4 Invesco India Infrastructure Fund Growth ₹64.52
↓ -0.26 ₹1,524 33.2 51.1 2.3 55.4 16.2 Kotak Infrastructure & Economic Reform Fund Growth ₹65.923
↓ -0.21 ₹2,313 32.4 37.3 15.6 57.3 3.4 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 23 Sep 25 Research Highlights & Commentary of 10 Funds showcased
Commentary LIC MF Infrastructure Fund UTI Healthcare Fund SBI Healthcare Opportunities Fund TATA India Pharma & Healthcare Fund Bandhan Infrastructure Fund Franklin India Opportunities Fund Canara Robeco Infrastructure Nippon India Pharma Fund Invesco India Infrastructure Fund Kotak Infrastructure & Economic Reform Fund Point 1 Bottom quartile AUM (₹995 Cr). Bottom quartile AUM (₹1,119 Cr). Upper mid AUM (₹3,963 Cr). Lower mid AUM (₹1,309 Cr). Upper mid AUM (₹1,613 Cr). Top quartile AUM (₹7,509 Cr). Bottom quartile AUM (₹889 Cr). Highest AUM (₹8,357 Cr). Lower mid AUM (₹1,524 Cr). Upper mid AUM (₹2,313 Cr). Point 2 Established history (17+ yrs). Oldest track record among peers (26 yrs). Established history (20+ yrs). Established history (9+ yrs). Established history (14+ yrs). Established history (25+ yrs). Established history (19+ yrs). Established history (21+ yrs). Established history (17+ yrs). Established history (17+ yrs). Point 3 Not Rated. Rating: 1★ (lower mid). Rating: 2★ (upper mid). Not Rated. Top rated. Rating: 3★ (upper mid). Not Rated. Rating: 2★ (lower mid). Rating: 3★ (upper mid). Rating: 4★ (top quartile). Point 4 Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: Moderately High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: High. Point 5 5Y return: 32.78% (top quartile). 5Y return: 18.36% (bottom quartile). 5Y return: 19.97% (lower mid). 5Y return: 18.28% (bottom quartile). 5Y return: 34.25% (top quartile). 5Y return: 29.57% (lower mid). 5Y return: 32.71% (upper mid). 5Y return: 17.99% (bottom quartile). 5Y return: 31.12% (upper mid). 5Y return: 31.24% (upper mid). Point 6 3Y return: 28.72% (top quartile). 3Y return: 26.16% (upper mid). 3Y return: 26.01% (lower mid). 3Y return: 23.79% (bottom quartile). 3Y return: 26.97% (upper mid). 3Y return: 28.87% (top quartile). 3Y return: 25.49% (lower mid). 3Y return: 23.38% (bottom quartile). 3Y return: 26.16% (upper mid). 3Y return: 22.11% (bottom quartile). Point 7 1Y return: -1.65% (lower mid). 1Y return: 2.30% (top quartile). 1Y return: 3.76% (top quartile). 1Y return: -0.54% (upper mid). 1Y return: -10.34% (bottom quartile). 1Y return: 0.73% (upper mid). 1Y return: -2.44% (lower mid). 1Y return: 0.12% (upper mid). 1Y return: -5.52% (bottom quartile). 1Y return: -8.69% (bottom quartile). Point 8 Alpha: -1.71 (bottom quartile). Alpha: 0.79 (upper mid). Alpha: 2.04 (upper mid). Alpha: 3.78 (top quartile). Alpha: 0.00 (upper mid). Alpha: 2.40 (top quartile). Alpha: 0.00 (lower mid). Alpha: -4.31 (bottom quartile). Alpha: 0.00 (lower mid). Alpha: -1.88 (bottom quartile). Point 9 Sharpe: -0.46 (lower mid). Sharpe: -0.15 (top quartile). Sharpe: -0.05 (top quartile). Sharpe: -0.39 (upper mid). Sharpe: -0.71 (bottom quartile). Sharpe: -0.43 (lower mid). Sharpe: -0.41 (upper mid). Sharpe: -0.47 (bottom quartile). Sharpe: -0.40 (upper mid). Sharpe: -0.52 (bottom quartile). Point 10 Information ratio: 0.34 (upper mid). Information ratio: 0.10 (upper mid). Information ratio: 0.38 (upper mid). Information ratio: 0.78 (top quartile). Information ratio: 0.00 (lower mid). Information ratio: 1.75 (top quartile). Information ratio: 0.00 (lower mid). Information ratio: -0.53 (bottom quartile). Information ratio: 0.00 (bottom quartile). Information ratio: -0.04 (bottom quartile). LIC MF Infrastructure Fund
UTI Healthcare Fund
SBI Healthcare Opportunities Fund
TATA India Pharma & Healthcare Fund
Bandhan Infrastructure Fund
Franklin India Opportunities Fund
Canara Robeco Infrastructure
Nippon India Pharma Fund
Invesco India Infrastructure Fund
Kotak Infrastructure & Economic Reform Fund
2019 ஆம் ஆண்டிற்கான சிறந்த செயல்திறன் துறை நிதி
The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. Research Highlights for UTI Healthcare Fund Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. Research Highlights for SBI Healthcare Opportunities Fund Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. Research Highlights for TATA India Pharma & Healthcare Fund Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. Research Highlights for Bandhan Infrastructure Fund Below is the key information for Bandhan Infrastructure Fund Returns up to 1 year are on The investment objective of Franklin India Opportunities Fund (FIOF) is to generate capital appreciation by capitalizing on the long-term growth opportunities in the Indian economy. Research Highlights for Franklin India Opportunities Fund Below is the key information for Franklin India Opportunities Fund Returns up to 1 year are on T o g e n e r a t e income/capital appreciation by investing in equities and equity related instruments of companies in the infrastructure sector. However, there can be no assurance that the investment objective of the scheme will be realized. Research Highlights for Canara Robeco Infrastructure Below is the key information for Canara Robeco Infrastructure Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Research Highlights for Nippon India Pharma Fund Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of infrastructure companies. However, there can be no assurance that the investment objective of the Scheme will be achieved. Research Highlights for Invesco India Infrastructure Fund Below is the key information for Invesco India Infrastructure Fund Returns up to 1 year are on The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly (at least 65%) equity and equity-related securities of companies involved in economic development of India as a result of potential investments in infrastructure and unfolding economic reforms. Research Highlights for Kotak Infrastructure & Economic Reform Fund Below is the key information for Kotak Infrastructure & Economic Reform Fund Returns up to 1 year are on 1. LIC MF Infrastructure Fund
LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (23 Sep 25) ₹50.3335 ↓ -0.10 (-0.20 %) Net Assets (Cr) ₹995 on 31 Aug 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.21 Sharpe Ratio -0.47 Information Ratio 0.34 Alpha Ratio -1.71 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹16,396 31 Aug 22 ₹18,753 31 Aug 23 ₹23,082 31 Aug 24 ₹41,121 31 Aug 25 ₹37,159 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Sep 25 Duration Returns 1 Month 3.3% 3 Month 2% 6 Month 14.2% 1 Year -1.7% 3 Year 28.7% 5 Year 32.8% 10 Year 15 Year Since launch 9.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.96 Yr. Mahesh Bendre 1 Jul 24 1.17 Yr. Data below for LIC MF Infrastructure Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 49.62% Basic Materials 8.63% Financial Services 8.16% Consumer Cyclical 6.96% Utility 6.68% Technology 4.17% Health Care 3.87% Real Estate 3.65% Communication Services 2.48% Energy 0.92% Asset Allocation
Asset Class Value Cash 4.87% Equity 95.13% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP6% ₹62 Cr 693,857
↑ 217,865 Larsen & Toubro Ltd (Industrials)
Equity, Since 30 Apr 09 | LT4% ₹40 Cr 109,584
↑ 6,093 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329553% ₹36 Cr 911,009
↑ 289,485 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Jun 25 | APOLLOHOSP3% ₹35 Cr 46,843
↑ 6,976 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006553% ₹33 Cr 94,287 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER3% ₹32 Cr 319,302 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹31 Cr 769,765 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 5004003% ₹29 Cr 724,927 Avalon Technologies Ltd (Technology)
Equity, Since 31 Jul 23 | AVALON3% ₹26 Cr 310,615
↓ -6,871 Mahindra Lifespace Developers Ltd (Real Estate)
Equity, Since 30 Jun 24 | MAHLIFE2% ₹25 Cr 666,245 2. UTI Healthcare Fund
UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (23 Sep 25) ₹294.065 ↓ -1.05 (-0.35 %) Net Assets (Cr) ₹1,119 on 31 Aug 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.26 Sharpe Ratio -0.15 Information Ratio 0.1 Alpha Ratio 0.79 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹14,183 31 Aug 22 ₹12,385 31 Aug 23 ₹15,093 31 Aug 24 ₹23,487 31 Aug 25 ₹24,105 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Sep 25 Duration Returns 1 Month -0.9% 3 Month 5.5% 6 Month 8.5% 1 Year 2.3% 3 Year 26.2% 5 Year 18.4% 10 Year 15 Year Since launch 15% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3.34 Yr. Data below for UTI Healthcare Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Health Care 96.62% Basic Materials 1.03% Asset Allocation
Asset Class Value Cash 2.34% Equity 97.66% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA10% ₹113 Cr 661,016 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000875% ₹62 Cr 400,000 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323315% ₹55 Cr 200,000
↓ -10,000 Lupin Ltd (Healthcare)
Equity, Since 28 Feb 25 | 5002574% ₹49 Cr 255,000
↑ 55,000 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹47 Cr 80,283 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY4% ₹46 Cr 360,000 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹41 Cr 190,000
↓ -60,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹40 Cr 465,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP3% ₹40 Cr 53,000 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND3% ₹34 Cr 166,863
↓ -13,137 3. SBI Healthcare Opportunities Fund
SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (22 Sep 25) ₹434.72 ↓ -3.67 (-0.84 %) Net Assets (Cr) ₹3,963 on 31 Aug 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 1.97 Sharpe Ratio -0.05 Information Ratio 0.38 Alpha Ratio 2.04 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹14,180 31 Aug 22 ₹12,913 31 Aug 23 ₹16,856 31 Aug 24 ₹24,718 31 Aug 25 ₹25,879 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Sep 25 Duration Returns 1 Month -0.7% 3 Month 4.1% 6 Month 4.4% 1 Year 3.8% 3 Year 26% 5 Year 20% 10 Year 15 Year Since launch 15.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 14.26 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Health Care 91.66% Basic Materials 5.96% Asset Allocation
Asset Class Value Cash 2.31% Equity 97.62% Debt 0.07% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA11% ₹461 Cr 2,700,000
↓ -100,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹290 Cr 440,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹262 Cr 2,100,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹187 Cr 1,200,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY4% ₹165 Cr 270,000
↓ -30,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002574% ₹162 Cr 840,000 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND4% ₹145 Cr 700,000
↑ 160,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹144 Cr 560,000 Acutaas Chemicals Ltd (Basic Materials)
Equity, Since 30 Jun 24 | 5433493% ₹133 Cr 1,000,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433083% ₹131 Cr 1,750,000
↓ -50,000 4. TATA India Pharma & Healthcare Fund
TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (23 Sep 25) ₹30.8535 ↓ -0.14 (-0.44 %) Net Assets (Cr) ₹1,309 on 31 Aug 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 2.17 Sharpe Ratio -0.39 Information Ratio 0.78 Alpha Ratio 3.78 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹14,514 31 Aug 22 ₹12,943 31 Aug 23 ₹15,786 31 Aug 24 ₹24,599 31 Aug 25 ₹24,182 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Sep 25 Duration Returns 1 Month -1.3% 3 Month 4.9% 6 Month 6.8% 1 Year -0.5% 3 Year 23.8% 5 Year 18.3% 10 Year 15 Year Since launch 12.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Rajat Srivastava 16 Sep 24 0.96 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Health Care 91.69% Financial Services 1.63% Basic Materials 0.46% Asset Allocation
Asset Class Value Cash 6.22% Equity 93.78% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA11% ₹146 Cr 856,462
↑ 2,162 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000877% ₹89 Cr 569,903
↑ 79,903 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP5% ₹70 Cr 92,826
↓ -34,429 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002575% ₹64 Cr 330,887
↑ 27,647 HealthCare Global Enterprises Ltd (Healthcare)
Equity, Since 31 Dec 18 | HCG4% ₹59 Cr 942,453
↑ 276,332 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | TORNTPHARM4% ₹58 Cr 154,717
↑ 83,796 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM4% ₹58 Cr 956,991 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328434% ₹54 Cr 624,597
↓ -230,503 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM4% ₹54 Cr 106,435
↑ 31,186 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Jul 25 | MAXHEALTH4% ₹51 Cr 407,917
↑ 407,917 5. Bandhan Infrastructure Fund
Bandhan Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (23 Sep 25) ₹50.322 ↓ -0.27 (-0.53 %) Net Assets (Cr) ₹1,613 on 31 Aug 25 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.1 Sharpe Ratio -0.71 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹19,221 31 Aug 22 ₹20,185 31 Aug 23 ₹26,032 31 Aug 24 ₹45,976 31 Aug 25 ₹39,818 Returns for Bandhan Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Sep 25 Duration Returns 1 Month 1.3% 3 Month 0.6% 6 Month 9.8% 1 Year -10.3% 3 Year 27% 5 Year 34.2% 10 Year 15 Year Since launch 11.7% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for Bandhan Infrastructure Fund
Name Since Tenure Vishal Biraia 24 Jan 24 1.6 Yr. Ritika Behera 7 Oct 23 1.9 Yr. Gaurav Satra 7 Jun 24 1.24 Yr. Data below for Bandhan Infrastructure Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 52.91% Utility 12.23% Basic Materials 7.2% Communication Services 4.75% Energy 3.76% Financial Services 3.28% Health Care 2.19% Technology 1.74% Consumer Cyclical 1.38% Real Estate 1.08% Asset Allocation
Asset Class Value Cash 9.47% Equity 90.53% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kirloskar Brothers Ltd (Industrials)
Equity, Since 31 Dec 17 | KIRLOSBROS5% ₹87 Cr 443,385 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT4% ₹75 Cr 206,262 Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 19 | BHARTIARTL4% ₹63 Cr 330,018 Reliance Industries Ltd (Energy)
Equity, Since 30 Jun 24 | RELIANCE4% ₹63 Cr 452,706 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 14 | 5325384% ₹61 Cr 49,772
↓ -680 GPT Infraprojects Ltd (Industrials)
Equity, Since 30 Nov 17 | GPTINFRA4% ₹61 Cr 4,733,244
↓ -49,289 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Oct 19 | BEL3% ₹55 Cr 1,431,700 PTC India Financial Services Ltd (Financial Services)
Equity, Since 31 Dec 23 | PFS3% ₹52 Cr 12,400,122 Adani Ports & Special Economic Zone Ltd (Industrials)
Equity, Since 31 Dec 23 | ADANIPORTS3% ₹50 Cr 365,137 Ahluwalia Contracts (India) Ltd (Industrials)
Equity, Since 30 Apr 15 | AHLUCONT3% ₹47 Cr 462,606 6. Franklin India Opportunities Fund
Franklin India Opportunities Fund
Growth Launch Date 21 Feb 00 NAV (22 Sep 25) ₹260.986 ↓ -1.38 (-0.53 %) Net Assets (Cr) ₹7,509 on 31 Aug 25 Category Equity - Sectoral AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 1.83 Sharpe Ratio -0.43 Information Ratio 1.75 Alpha Ratio 2.4 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹16,290 31 Aug 22 ₹16,765 31 Aug 23 ₹21,341 31 Aug 24 ₹35,884 31 Aug 25 ₹35,247 Returns for Franklin India Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Sep 25 Duration Returns 1 Month 1.8% 3 Month 5.5% 6 Month 14.6% 1 Year 0.7% 3 Year 28.9% 5 Year 29.6% 10 Year 15 Year Since launch 13.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 37.3% 2023 53.6% 2022 -1.9% 2021 29.7% 2020 27.3% 2019 5.4% 2018 -10.1% 2017 35.6% 2016 4.2% 2015 2.3% Fund Manager information for Franklin India Opportunities Fund
Name Since Tenure Kiran Sebastian 7 Feb 22 3.57 Yr. R. Janakiraman 1 Apr 13 12.43 Yr. Sandeep Manam 18 Oct 21 3.87 Yr. Data below for Franklin India Opportunities Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Financial Services 19.78% Consumer Cyclical 18.45% Health Care 14.12% Technology 11.61% Basic Materials 9.22% Communication Services 5.73% Energy 5.1% Industrials 4.14% Utility 2.87% Consumer Defensive 1.83% Real Estate 0.84% Asset Allocation
Asset Class Value Cash 6.31% Equity 93.69% Top Securities Holdings / Portfolio
Name Holding Value Quantity HDFC Bank Ltd (Financial Services)
Equity, Since 31 May 24 | HDFCBANK6% ₹413 Cr 2,043,971 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE5% ₹376 Cr 2,707,279
↓ -331,689 Axis Bank Ltd (Financial Services)
Equity, Since 30 Apr 25 | 5322154% ₹315 Cr 2,950,277 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Aug 23 | 5433204% ₹294 Cr 9,548,090
↓ -582,172 Mphasis Ltd (Technology)
Equity, Since 30 Nov 24 | 5262993% ₹227 Cr 814,231
↑ 103,698 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Jan 24 | BHARTIARTL3% ₹222 Cr 1,158,502
↓ -183,731 Maruti Suzuki India Ltd (Consumer Cyclical)
Equity, Since 30 Apr 25 | MARUTI3% ₹214 Cr 169,582 NTPC Ltd (Utilities)
Equity, Since 31 Aug 22 | 5325553% ₹212 Cr 6,333,312 Sudarshan Chemical Industries Ltd (Basic Materials)
Equity, Since 30 Apr 24 | SUDARSCHEM3% ₹206 Cr 1,435,340 Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 May 24 | M&M3% ₹204 Cr 637,966 7. Canara Robeco Infrastructure
Canara Robeco Infrastructure
Growth Launch Date 2 Dec 05 NAV (23 Sep 25) ₹163.69 ↑ 0.01 (0.01 %) Net Assets (Cr) ₹889 on 31 Aug 25 Category Equity - Sectoral AMC Canara Robeco Asset Management Co. Ltd. Rating Risk High Expense Ratio 2.32 Sharpe Ratio -0.41 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹17,138 31 Aug 22 ₹20,330 31 Aug 23 ₹23,805 31 Aug 24 ₹39,908 31 Aug 25 ₹38,048 Returns for Canara Robeco Infrastructure
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Sep 25 Duration Returns 1 Month 2.4% 3 Month 2.9% 6 Month 13.5% 1 Year -2.4% 3 Year 25.5% 5 Year 32.7% 10 Year 15 Year Since launch 15.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 35.3% 2023 41.2% 2022 9% 2021 56.1% 2020 9% 2019 2.3% 2018 -19.1% 2017 40.2% 2016 2.1% 2015 6.7% Fund Manager information for Canara Robeco Infrastructure
Name Since Tenure Vishal Mishra 26 Jun 21 4.19 Yr. Shridatta Bhandwaldar 29 Sep 18 6.93 Yr. Data below for Canara Robeco Infrastructure as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 45.06% Utility 12.61% Basic Materials 10.12% Energy 8.15% Financial Services 6.69% Technology 5.72% Consumer Cyclical 2.94% Communication Services 2.85% Real Estate 1.37% Asset Allocation
Asset Class Value Cash 4.48% Equity 95.52% Top Securities Holdings / Portfolio
Name Holding Value Quantity Larsen & Toubro Ltd (Industrials)
Equity, Since 28 Feb 11 | LT8% ₹72 Cr 197,901
↑ 5,000 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE4% ₹39 Cr 279,250
↑ 15,000 NTPC Ltd (Utilities)
Equity, Since 30 Nov 18 | 5325554% ₹36 Cr 1,066,480 InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 Jan 23 | INDIGO4% ₹34 Cr 58,250 State Bank of India (Financial Services)
Equity, Since 31 Jul 24 | SBIN4% ₹34 Cr 430,000 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Jul 19 | BEL4% ₹33 Cr 869,000
↓ -50,000 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222754% ₹33 Cr 119,833
↓ -3,000 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Oct 23 | DIXON3% ₹32 Cr 18,950
↑ 1,750 Tata Power Co Ltd (Utilities)
Equity, Since 30 Sep 24 | 5004003% ₹31 Cr 785,000 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 31 Oct 09 | 5328983% ₹28 Cr 957,546 8. Nippon India Pharma Fund
Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (23 Sep 25) ₹515.509 ↓ -2.04 (-0.39 %) Net Assets (Cr) ₹8,357 on 31 Aug 25 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 1.81 Sharpe Ratio -0.48 Information Ratio -0.53 Alpha Ratio -4.31 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹14,796 31 Aug 22 ₹12,973 31 Aug 23 ₹16,262 31 Aug 24 ₹24,360 31 Aug 25 ₹23,858 Returns for Nippon India Pharma Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Sep 25 Duration Returns 1 Month -0.8% 3 Month 2.2% 6 Month 5.8% 1 Year 0.1% 3 Year 23.4% 5 Year 18% 10 Year 15 Year Since launch 20.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 34% 2023 39.2% 2022 -9.9% 2021 23.9% 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 20.43 Yr. Kinjal Desai 25 May 18 7.28 Yr. Data below for Nippon India Pharma Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Health Care 99.45% Asset Allocation
Asset Class Value Cash 0.55% Equity 99.45% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA12% ₹1,068 Cr 6,256,349 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB8% ₹660 Cr 1,000,031
↓ -70,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 5002576% ₹518 Cr 2,683,991 Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 5000876% ₹497 Cr 3,200,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | DRREDDY6% ₹497 Cr 3,916,074
↑ 453,904 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSP6% ₹486 Cr 648,795 Medplus Health Services Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5434274% ₹338 Cr 3,627,277 Vijaya Diagnostic Centre Ltd (Healthcare)
Equity, Since 30 Sep 21 | 5433504% ₹310 Cr 2,886,684 GlaxoSmithKline Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | GLAXO3% ₹289 Cr 913,226
↓ -5,938 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND3% ₹273 Cr 1,320,549
↓ -208,803 9. Invesco India Infrastructure Fund
Invesco India Infrastructure Fund
Growth Launch Date 21 Nov 07 NAV (23 Sep 25) ₹64.52 ↓ -0.26 (-0.40 %) Net Assets (Cr) ₹1,524 on 31 Aug 25 Category Equity - Sectoral AMC Invesco Asset Management (India) Private Ltd Rating ☆☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio -0.4 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹16,507 31 Aug 22 ₹18,498 31 Aug 23 ₹22,765 31 Aug 24 ₹38,345 31 Aug 25 ₹35,557 Returns for Invesco India Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Sep 25 Duration Returns 1 Month 0.8% 3 Month 0.7% 6 Month 13.7% 1 Year -5.5% 3 Year 26.2% 5 Year 31.1% 10 Year 15 Year Since launch 11% Historical performance (Yearly) on absolute basis
Year Returns 2024 33.2% 2023 51.1% 2022 2.3% 2021 55.4% 2020 16.2% 2019 6.1% 2018 -15.8% 2017 48.1% 2016 0.8% 2015 -2.6% Fund Manager information for Invesco India Infrastructure Fund
Name Since Tenure Amit Nigam 3 Sep 20 5 Yr. Sagar Gandhi 1 Mar 25 0.5 Yr. Data below for Invesco India Infrastructure Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 55.46% Basic Materials 9.93% Consumer Cyclical 8.6% Communication Services 6.36% Utility 5.32% Real Estate 4.39% Health Care 3.71% Technology 2.91% Energy 2.3% Asset Allocation
Asset Class Value Cash 1.03% Equity 98.97% Top Securities Holdings / Portfolio
Name Holding Value Quantity Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Aug 21 | BHARTIARTL6% ₹100 Cr 521,351 Delhivery Ltd (Industrials)
Equity, Since 31 Aug 24 | 5435295% ₹72 Cr 1,698,708 Supreme Industries Ltd (Industrials)
Equity, Since 30 Apr 24 | 5099304% ₹63 Cr 146,832
↓ -3,558 PTC Industries Ltd (Industrials)
Equity, Since 30 Sep 24 | 5390063% ₹53 Cr 35,841 Ramco Cements Ltd (Basic Materials)
Equity, Since 31 Jul 23 | RAMCOCEM3% ₹53 Cr 448,912 ZF Commercial Vehicle Control Systems India Ltd (Consumer Cyclical)
Equity, Since 30 Jun 23 | ZFCVINDIA3% ₹49 Cr 37,138 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 30 Apr 22 | 5328983% ₹48 Cr 1,650,305
↓ -325,287 Indian Railway Catering And Tourism Corp Ltd (Industrials)
Equity, Since 30 Apr 24 | IRCTC3% ₹47 Cr 642,726
↓ -41,062 Honeywell Automation India Ltd (Industrials)
Equity, Since 30 Sep 20 | HONAUT3% ₹46 Cr 11,992
↑ 4,698 Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Sep 22 | DIXON3% ₹46 Cr 27,141
↓ -4,935 10. Kotak Infrastructure & Economic Reform Fund
Kotak Infrastructure & Economic Reform Fund
Growth Launch Date 25 Feb 08 NAV (23 Sep 25) ₹65.923 ↓ -0.21 (-0.32 %) Net Assets (Cr) ₹2,313 on 31 Aug 25 Category Equity - Sectoral AMC Kotak Mahindra Asset Management Co Ltd Rating ☆☆☆☆ Risk High Expense Ratio 2.01 Sharpe Ratio -0.52 Information Ratio -0.04 Alpha Ratio -1.88 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Aug 20 ₹10,000 31 Aug 21 ₹17,231 31 Aug 22 ₹20,526 31 Aug 23 ₹25,737 31 Aug 24 ₹39,858 31 Aug 25 ₹35,926 Returns for Kotak Infrastructure & Economic Reform Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Sep 25 Duration Returns 1 Month 1.2% 3 Month 2.1% 6 Month 14.5% 1 Year -8.7% 3 Year 22.1% 5 Year 31.2% 10 Year 15 Year Since launch 11.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 32.4% 2023 37.3% 2022 15.6% 2021 57.3% 2020 3.4% 2019 3.6% 2018 -19.6% 2017 45.3% 2016 9.2% 2015 -0.2% Fund Manager information for Kotak Infrastructure & Economic Reform Fund
Name Since Tenure Nalin Bhatt 1 Oct 23 1.92 Yr. Data below for Kotak Infrastructure & Economic Reform Fund as on 31 Aug 25
Equity Sector Allocation
Sector Value Industrials 44.55% Basic Materials 14.91% Communication Services 10.97% Consumer Cyclical 10.29% Energy 8.35% Utility 4.88% Real Estate 2.05% Financial Services 1.72% Technology 1.21% Asset Allocation
Asset Class Value Cash 0.97% Equity 99.03% Top Securities Holdings / Portfolio
Name Holding Value Quantity Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 20 | BHARTIARTL7% ₹177 Cr 927,000 Reliance Industries Ltd (Energy)
Equity, Since 31 Mar 25 | RELIANCE5% ₹125 Cr 900,000 Larsen & Toubro Ltd (Industrials)
Equity, Since 28 Feb 15 | LT5% ₹113 Cr 310,000 Shree Cement Ltd (Basic Materials)
Equity, Since 31 Dec 11 | 5003875% ₹108 Cr 35,000 Solar Industries India Ltd (Basic Materials)
Equity, Since 31 Oct 15 | SOLARINDS3% ₹77 Cr 54,000
↓ -18,000 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 15 | 5325383% ₹73 Cr 60,000 Kalpataru Projects International Ltd (Industrials)
Equity, Since 31 Aug 17 | KPIL3% ₹73 Cr 639,927 Bosch Ltd (Consumer Cyclical)
Equity, Since 30 Sep 24 | 5005303% ₹71 Cr 17,500 Kajaria Ceramics Ltd (Industrials)
Equity, Since 31 Oct 16 | 5002333% ₹60 Cr 510,000
↓ -90,000 VST Tillers Tractors Ltd (Industrials)
Equity, Since 30 Apr 24 | VSTTILLERS3% ₹60 Cr 130,659
இங்கு வழங்கப்பட்ட தகவல்கள் துல்லியமானவை என்பதை உறுதிப்படுத்த அனைத்து முயற்சிகளும் மேற்கொள்ளப்பட்டுள்ளன. இருப்பினும், தரவின் சரியான தன்மை குறித்து எந்த உத்தரவாதமும் அளிக்கப்படவில்லை. எந்தவொரு முதலீடும் செய்வதற்கு முன் திட்ட தகவல் ஆவணத்துடன் சரிபார்க்கவும்.
You Might Also Like
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved
Research Highlights for LIC MF Infrastructure Fund